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Introduction
Autoinflammatory diseases (AID) are rare disorders char-
acterized by recurrent episodes of systemic and organ-
specific inflammation. Studying AID has been limited by
the difficulty in finding and enrolling large numbers of
patients with these rare illnesses. We used a traditional
retrospective chart review to describe patients with AID
at a single academic medical center, and compared the
results with those of participants within the Childhood
Arthritis and Rheumatology Research Alliance (CARRA)
Registry, a multicenter observational pediatric rheumatic
disease registry in North America. We discuss the bene-
fits and limitations of these types of studies, and suggest
new ways to conduct future research.
Methods
We included patients with a clinical or genetic diagnosis
of AID. We conducted a retrospective chart review at
Boston Children’s Hospital (BCH) from 2002-2012.
Charts were identified by keywords and billing codes
related to AID, and patients with CRMO were excluded.
We also conducted a cross-sectional study of children
with AID enrolled in the CARRA registry from May
2011 to December 2013.
Results
At BCH, we identified 169 subjects with AID. In the
CARRA registry, of 9,523 subjects enrolled, 87 patients
had AID. The distribution of diagnoses from patients at
BCH included PFAPA (48%), FMF (22%), TRAPS (2%),
MKD (2%), NOMID (2%), FCAS (2%), and undefined
(23%). In the CARRA registry, diagnoses included CRMO
(39%), FMF (17%), PFAPA (10%), TRAPS (7%), NOMID
(3%), MWS (3%), SAPHO (2%), PAPA (1%), FCAS (1%),
MKD (1%), and undefined (14%).
Conclusions
The past
Using the traditional method of a single-center retro-
spective chart review, we described the patients with
AID seen at BCH over a 10-year period. This research
required little cost and relatively little time. Limitations
included incomplete documentation of some patients,
and the variety of AID which were identified.
The present
The CARRA registry was a multicenter effort where
patients were enrolled at a faster rate, and with a greater
variety of diagnoses. However, this registry required sig-
nificant financial investments in technology and opera-
tional costs. PFAPA, the most common pediatric AID,
represented only a minority of subjects within the
CARRA registry, suggesting an enrolment bias, perhaps
due to the time required for consent, enrolment, and
data-uploading process.
The future
Future registries will likely be integrated into the patient’s
electronic health records, avoiding many of the current
barriers to research. In addition, we believe that online
patient communities can contribute valuable information
regarding patient-reported outcomes. In future studies,
we plan to empower and engage patients with AID
through social media to collaborate in design and
research implementation. Our efforts will exponentially
expand the number of patients available to participate in
research, and will provide more complete and meaningful
data.
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